Soriot must explain why AstraZeneca deal collapsed
AstraZeneca CEO Pascal Soriot is facing calls to clarify what prevented a major deal from going through. Investors and industry watchers want transparency about the collapsed transaction. The explanation could shape confidence in AstraZeneca's leadership and its future strategic moves.